Zirconium Cyclosilicate for Treatment of Hyperkalemia

Overview of attention for article published in JAMA: Journal of the American Medical Association, December 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

news: 6 news outlets
blogs: 2 blogs

policy: 1 policy source
twitter: 9 X users

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 6 news stories from 6 outlets.

Novel oral hyperkalemia drug shows promise in phase III trial

Pediatric News , 31 May 2026

AT THE AHA SCIENTIFIC SESSIONS The oral drug sodium zirconium cyclosilicate may offer an effective new treatment option for…

Drug Lowers High Potassium Levels Associated with Potentially Lethal Cardiac Arrhythmias

Science Newsline, 17 Nov 2014

Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and…

Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias

Science Daily, 17 Nov 2014

Researchers evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia -- higher than…

Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias

MedicalXpress, 17 Nov 2014

Mikhail Kosiborod, M.D., of Saint Luke's Mid America Heart Institute, Kansas City, and colleagues evaluated the efficacy and…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 2 additional news stories.